| HMDB 4.0: the human metabolome database for 2018 DS Wishart, YD Feunang, A Marcu, AC Guo, K Liang, R Vázquez-Fresno, ... Nucleic acids research 46 (D1), D608-D617, 2018 | 3745 | 2018 |
| CD4+ follicular helper T cell infiltration predicts breast cancer survival C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ... The Journal of clinical investigation 123 (7), 2873-2892, 2013 | 1129 | 2013 |
| Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ... Nature genetics 50 (7), 928-936, 2018 | 921 | 2018 |
| Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling HA Azim Jr, S Michiels, PL Bedard, SK Singhal, C Criscitiello, M Ignatiadis, ... Clinical cancer research 18 (5), 1341-1351, 2012 | 443 | 2012 |
| Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ... Nature genetics 53 (1), 65-75, 2021 | 409 | 2021 |
| Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis M Ignatiadis, SK Singhal, C Desmedt, B Haibe-Kains, C Criscitiello, ... Journal of clinical oncology 30 (16), 1996-2004, 2012 | 248 | 2012 |
| DNA methylation profiling reveals a predominant immune component in breast cancers S Dedeurwaerder, C Desmedt, E Calonne, SK Singhal, B Haibe‐Kains, ... EMBO molecular medicine 3 (12), 726-741, 2011 | 248 | 2011 |
| HER2-positive circulating tumor cells in breast cancer M Ignatiadis, F Rothe, C Chaboteaux, V Durbecq, G Rouas, C Criscitiello, ... PloS one 6 (1), e15624, 2011 | 234 | 2011 |
| Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants T Dadaev, EJ Saunders, PJ Newcombe, E Anokian, DA Leongamornlert, ... Nature communications 9 (1), 2256, 2018 | 114 | 2018 |
| Radiogenomics consortium genome-wide association study meta-analysis of late toxicity after prostate cancer radiotherapy SL Kerns, L Fachal, L Dorling, GC Barnett, A Baran, DR Peterson, ... JNCI: Journal of the National Cancer Institute 112 (2), 179-190, 2020 | 104 | 2020 |
| PIK3CA genotype and a PIK3CA mutation-related gene signature and response to everolimus and letrozole in estrogen receptor positive breast cancer S Loi, S Michiels, J Baselga, JMS Bartlett, SK Singhal, VS Sabine, ... PloS one 8 (1), e53292, 2013 | 98 | 2013 |
| The prediction of radiotherapy toxicity using single nucleotide polymorphism− based models: a step toward prevention SL Kerns, S Kundu, JH Oh, SK Singhal, M Janelsins, LB Travis, JO Deasy, ... Seminars in radiation oncology 25 (4), 281-291, 2015 | 80 | 2015 |
| Genomic grade adds prognostic value in invasive lobular carcinoma O Metzger-Filho, S Michiels, F Bertucci, A Catteau, R Salgado, C Galant, ... Annals of oncology 24 (2), 377-384, 2013 | 72 | 2013 |
| Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants A Wang, J Shen, AA Rodriguez, EJ Saunders, F Chen, R Janivara, ... Nature genetics 55 (12), 2065-2074, 2023 | 70 | 2023 |
| Characterization and Clinical Evaluation of CD10+ Stroma Cells in the Breast Cancer Microenvironment C Desmedt, S Majjaj, N Kheddoumi, SK Singhal, B Haibe-Kains, ... Clinical cancer research 18 (4), 1004-1014, 2012 | 63 | 2012 |
| Synergistic approach using platelet‐rich fibrin and 1% alendronate for intrabony defect treatment in chronic periodontitis: a randomized clinical trial D Kanoriya, AR Pradeep, S Singhal, V Garg, CN Guruprasad Journal of periodontology 87 (12), 1427-1435, 2016 | 55 | 2016 |
| Comparative evaluation of subgingivally delivered 1% alendronate versus 1.2% atorvastatin gel in treatment of chronic periodontitis: a randomized placebo‐controlled clinical trial AR Pradeep, D Kanoriya, S Singhal, V Garg, B Manohar, A Chatterjee Journal of investigative and clinical dentistry 8 (3), e12215, 2017 | 49 | 2017 |
| Association between SPARC mRNA expression, prognosis and response to neoadjuvant chemotherapy in early breast cancer: a pooled in-silico analysis HA Azim Jr, S Singhal, M Ignatiadis, C Desmedt, D Fumagalli, I Veys, ... PloS one 8 (4), e62451, 2013 | 48 | 2013 |
| Liquid biopsy in lung cancer screening: the contribution of metabolomics. Results of a pilot study S Singhal, C Rolfo, AW Maksymiuk, PS Tappia, DS Sitar, A Russo, ... Cancers 11 (8), 1069, 2019 | 33 | 2019 |
| Racial differences in the association between luminal master regulator gene expression levels and breast cancer survival JS Byun, SK Singhal, S Park, DI Yi, T Yan, A Caban, A Jones, ... Clinical Cancer Research 26 (8), 1905-1914, 2020 | 30 | 2020 |
